Indian pharma on alert as US mulls higher drug tariffs

Indian drug makers are assessing the potential consequences of additional tariffs imposed by the US in response to India's oil purchases from Russia. While previous tariffs spared pharmaceuticals, uncertainty prevails due to frequent policy changes. Companies are exploring mitigation strategies like price adjustments and technology transfer to the US, anticipating manageable impacts on medicine access.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/JTxi1wE
via IFTTT